⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11240898 | 0.71 | — | — | |
| SCHEMBL930480 | 0.67 | — | — | |
| SCHEMBL1201995 | 0.67 | — | — | |
| SCHEMBL1764437 | 0.67 | — | — | |
| SCHEMBL4918732 | 0.62 | — | — | |
| SCHEMBL4923766 | 0.62 | — | — | |
| SCHEMBL11696210 | 0.59 | — | — | |
| SCHEMBL17103455 | 0.58 | — | — | |
| SCHEMBL4398562 | 0.57 | — | — | |
| SCHEMBL5007434 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230278996-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE S.A. (PL) | 2023-09-07 | — | — | US | claimed |
| CN-110713588-B | Hardmask composition, hardmask layer and method of forming pattern | 三星SDI株式会社 | 2022-08-09 | — | — | CN | claimed |
| US-11214678-B2 | Hardmask composition, hardmask layer and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2022-01-04 | — | — | US | claimed |
| CN-110713588-A | Hardmask composition, hardmask layer and method of forming pattern | 三星SDI株式会社 | 2020-01-21 | — | — | CN | claimed |
| EP-2408930-B1 | BIOTINIDASE ASSAY | WALLAC OY (FI) | 2015-05-06 | — | — | EP | claimed |
| US-8597903-B2 | Biotinidase assay | WALLAC OY (FI) | 2013-12-03 | — | — | US | claimed |
| US-20120045784-A1 | BIOTINIDASE ASSAY | Joachim Ngiamas trustee for Joachim Ngiam Trust Fund ABN | 2012-02-23 | — | — | US | claimed |
| EP-2408930-A2 | BIOTINIDASE ASSAY | WALLAC OY (FI) | 2012-01-25 | — | — | EP | claimed |
| WO-2010106222-A2 | BIOTINIDASE ASSAY | WALLAC OY (FI) | 2010-09-23 | — | — | WO | claimed |
| US-5641783-A | ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS | CELL THERAPEUTICS, INC. (US) | 1997-06-24 | — | — | US | claimed |
| US-20230278996-A1 | YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS | MOLECURE S.A. (PL) | 2023-09-07 | — | — | US | disclosed |
| CN-110713588-B | Hardmask composition, hardmask layer and method of forming pattern | 三星SDI株式会社 | 2022-08-09 | — | — | CN | disclosed |
| CN-114727991-A | Arylmethylene heterocyclic compounds as Kv1.3 potassium SHAKER channel blockers | D·E·萧尔研究有限责任公司 | 2022-07-08 | — | — | CN | disclosed |
| US-11214678-B2 | Hardmask composition, hardmask layer and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2022-01-04 | — | — | US | disclosed |
| CN-110713588-A | Hardmask composition, hardmask layer and method of forming pattern | 三星SDI株式会社 | 2020-01-21 | — | — | CN | disclosed |
| EP-0233780-A2 | O-substituted oximino cephalosporins | ELI LILLY AND COMPANY (US) | 1987-08-26 | — | — | EP | disclosed |
| EP-0064378-B1 | AFFINITY CHROMATOGRAPHY USING METAL IONS | The Public Health Laboratory Service Board (GB) | 1987-02-11 | — | — | EP | disclosed |
| US-4431546-A | SEPARATION OF BIOLOGICAL MATERIAL IN A SOLUTION CONTAINING A METAL SALT USING A MATRIX-DYE LIGAND | THE PUBLIC HEALTH LABORATORY SERVICES BOARD (GB) | 1984-02-14 | — | — | US | disclosed |
| EP-0068297-A1 | A new insecticidal composition, processes for its production and its use | A. Nattermann & Cie. GmbH (DE) | 1983-01-05 | — | — | EP | disclosed |
| EP-0064378-A2 | Affinity chromatography using metal ions | The Public Health Laboratory Service Board (GB) | 1982-11-10 | — | — | EP | disclosed |